MMP9 production by human monocyte-derived macrophages is decreased on polymerized type I collagen

Journal of Vascular Surgery

Volumn 34, Issue 6, 2001, Pages 1111-1118

  Lepidi, Sandro ^a   Kenagy, Richard D ^a   Raines, Elaine W ^a   Chiu, Ernest S ^a   Chait, Alan ^a   Ross, Russell ^a   Clowes, Alexander W ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Box 356410 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CYTOKINE; GELATINASE B; GROWTH PROMOTOR; POLYMER; TUMOR NECROSIS FACTOR;

AORTA ANEURYSM; ARTERIOSCLEROSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL SIZE; CULTURE MEDIUM; DRUG EFFECT; ENZYMOLOGY; EXTRACELLULAR SPACE; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; METHODOLOGY; MONOCYTE; PHYSIOLOGY; SERODIAGNOSIS; STANDARD;

AORTIC ANEURYSM; ARTERIOSCLEROSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL SIZE; COLLAGEN TYPE I; CULTURE MEDIA; CYTOKINES; EXTRACELLULAR SPACE; GELATINASE B; GROWTH SUBSTANCES; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MONOCYTES; POLYMERS; PRECIPITIN TESTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0035650675     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.119401     Document Type: Article

References (40)

1. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94: 2493-503.
2. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A 1991;88: 8154-8.
3. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A 1996;93:9748-53.
4. Herron GS, Unemori E, Wong M, Rapp JH, Hibbs MH, Stoney RJ. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb Vase Biol 1991;11:1667-77.
5. Davis V, Persidskaia R, Baca-Regen L, Itoh Y, Nagase H, Persidsky Y, et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vase Biol 1998;18:1625-33.
6. Kenagy RD, Nikkari ST, Welgus HG, Clowes AW. Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. J Clin Invest 1994;93:1987-93.
7. Xia MH, Leppert D, Hauser SL, Sreedharan SP, Nelson PJ, Krensky AM, et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol 1996;156:160-7.
8. Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM, et al. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest 1990;86:1496-502.
9. Hanemaaijer R, Koolwijk P, Le Clercq L, De Vree WJA, Van Hinsbergh VWM. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumor necrosis factor α, interleukin 1 and phorbol ester. Biochem J 1993; 296:803-9.
10. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993;69:377-81.
11. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques - potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995;92:1565-9.
12. Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, Tipping P, et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 1997;17:439-44.
13. Allaire E, Hasenstab D, Kenagy RD, Starcher B, Clowes MM, Clowes AW. Prevention of aneurysm development and rupture by local over-expression of plasminogen activator inhibitor-1. Circulation 1998;98: 249-55.
14. Allaire E, Forough R, Clowes W, Starcher B, Clowes AW. Local over-expression of TIMP-I prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 1998;102:1413-20.
15. Sharpiro SD, Campbell EJ, Senior RM, Welgus HG. Proteinases secreted by human mononuclear phagocytes. J Rheumatol 1991;18: 95-8.
16. Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T, Welgus HG, Alpers CE, et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 1995;92:1393-8.
17. Shapiro SD, Kobayashi DK, Pentland AP, Welgus HG. Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. J Biol Chem 1993;268:8170-5.
18. Vu TH, Werb Z. Gelatinase B: structure, regulation, and function. In: Parks WC, Mecham RP, editors. Matrix metalloproteinases. San Diego: Academic Press; 1998. p. 115-48.
19. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 1995;91:2125-31.
20. Wilhelm SM, Collier I, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV-40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989;264:17213-21.
21. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 1968;97:77-89.
22. Nakano T, Raines EW, Abraham JA, Klagsbrun M, Ross R. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci U S A 1994;91:1069-73.
23. Davies PF, Ross R. Mediation of pinocytosis in cultured arterial smooth muscle and endothelial cells by platelet-derived growth factor. J Cell Biol 1978;79:663-71.
24. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979;76:333-7.
25. Bierman EL, Stein O, Stein Y. Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture. Circ Res 1974;35:136-50.
26. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 1983;49:327-33.
27. Aepfelbacher M, Vauti F, Weber PC, Glomset JA. Spreading of differentiating human monocytes is associated with a major increase in membrane-bound CDC42. Proc Natl Acad Sci U S A 1994;91:4263-7.
28. Stevenson HC, Katz P, Wright DG, Contreras TJ, Jemionek JF, Hartwig VM, et al. Human blood monocytes: characterization of negatively selected human monocytes and their suspension cell culture derivatives. Scand J Immunol 1981;14:243-56.
29. Wesley II RB, Meng X, Godin D, Galis ZS. Extracellular matrix modulates macrophage functions characteristic to atheroma; collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. Arterioscler Thromb Vase Biol 1998; 18:432-40.
30. Khan KM, Falcone DJ. Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression. J Biol Chem 1997;272:8270-5.
31. Pickering JG, Ford CM, Chow LH. Evidence for rapid accumulation and persistently disordered architecture of fibrillar collagen in human coronary restenosis lesions. Am J Cardiol 1996;78:633-7.
32. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999;99:2503-9.
33. 1 integrin in HL-60 cells. J Biol Chem 1998;273:11583-8.
34. Janowska-Wieczorek A, Marquez LA, Nabholtz JM, Cabuhat ML, Montano J, Chang H, et al. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane. Blood 1999; 93:3379-90.
35. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990;248:1009-12.
36. Inaba T, Shimano H, Gotoda T, Harada K, Shimada M, Ohsuga J, et al. Expression of platelet-derived growth factor β receptor on human monocyte-derived macrophages and effects of platelet-derived growth factor BB dimer on the cellular function. J Biol Chem 1993;268: 24353-60.
37. Kretteck A, Fager G, Lindmark H, Simonson C, Lustig F. Effect of phenotype on the transcription of the genes for platelet-derived growth factor (PDGF) isoforms in human smooth muscle cells, monocyte-derived macrophages, and endothelial cells in vitro. Arterioscler Thromb Vasc Biol 1997;17:2897-903.
38. Fabunmi RP, Baker AH, Murray EJ, Booth RFG, Newby AC. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors of metalloproteinases-1, -2 and -3 in rabbit aortic smooth muscle cells. Biochem J 1996;315:335-42.
39. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 1995;25:S9-12.
40. Yan X-Q, Brady G, Iscove NN. Platelet-derived growth factor (PDGF) activates primitive hematopoietic precursors (pre-CSFmulti) by up-regulating IL-1 in PDGF receptor-express ing macrophages. J Immunol 1993;150:2440-8.